Home
>
National Drug Code (NDC)
>
Famciclovir
Famciclovir - 42291-275-30 - (Famciclovir)
Drug Information of Famciclovir
| Product NDC: | 42291-275 |
| Proprietary Name: | Famciclovir |
| Non Proprietary Name: | Famciclovir |
| Active Ingredient(s): | 125 mg/1 & nbsp; Famciclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Famciclovir
| Product NDC: | 42291-275 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077487 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120104 |
Package Information of Famciclovir
| Package NDC: | 42291-275-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42291-275-30) |
NDC Information of Famciclovir
| NDC Code | 42291-275-30 |
| Proprietary Name | Famciclovir |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42291-275-30) |
| Product NDC | 42291-275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Famciclovir |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120104 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | FAMCICLOVIR |
| Strength Number | 125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
